Literature DB >> 18087216

TRAF4 is potently induced by TAp63 isoforms and localised according to differentiation in SCCHN.

Xiaolian Gu1, Philip J Coates, Stephanie F MacCallum, Linda Boldrup, Björn Sjöström, Karin Nylander.   

Abstract

p63, a member of the p53 family, is overexpressed in squamous cell carcinoma of the head and neck (SCCHN) and some other tumors of epithelial origin. As a transcription factor, p63 can bind to p53-type response elements and there is some overlap between p53 family transcriptional targets. Tumor necrosis factor receptor associated factor 4 (TRAF4) is a p53 regulated gene which is overexpressed in many human carcinomas. We investigated the involvement of p63 in regulation of TRAF4 and the expression of the TRAF4 protein in SCCHN. Disrupting endogenous p63 expression resulted in downregulation of TRAF4 mRNA and protein in an SCCHN cell line. Endogenous p63 bound to the TRAF4 promoter in vivo and reporter assays showed that p63, p73 and p53 can all transactivate TRAF4, with TAp63 isoforms being the most potent activators. The level of TRAF4 activation by TAp63 was two-fold higher than by p53, and TRAF4 was ten-fold more responsive to TAp63 than another p63-target, IGFBP3. Nuclear expression of TRAF4 was seen in normal oral epithelium and highly/moderately differentiated SCCHN, whereas cytoplasmic expression of TRAF4 was seen in poorly differentiated SCCHN. These results indicate that TRAF4 is a common target of p53 family members and that localization of TRAF4 is associated with differentiation of SCCHN cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087216     DOI: 10.4161/cbt.6.12.5002

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  5 in total

1.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

Review 2.  The Research Progress in Physiological and Pathological Functions of TRAF4.

Authors:  Xueqin Ruan; Rong Zhang; Ruijuan Li; Hongkai Zhu; Zhihua Wang; Canfei Wang; Zhao Cheng; Hongling Peng
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

3.  A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.

Authors:  Ling Wu; Xing Chen; Junjie Zhao; Bradley Martin; Jarod A Zepp; Jennifer S Ko; Chunfang Gu; Gang Cai; Wenjun Ouyang; Ganes Sen; George R Stark; Bing Su; Charlotte M Vines; Cathy Tournier; Thomas A Hamilton; Allison Vidimos; Brian Gastman; Caini Liu; Xiaoxia Li
Journal:  J Exp Med       Date:  2015-09-07       Impact factor: 14.307

4.  TRAF4, at the Crossroad between Morphogenesis and Cancer.

Authors:  Adrien Rousseau; Marie-Christine Rio; Fabien Alpy
Journal:  Cancers (Basel)       Date:  2011-06-21       Impact factor: 6.639

5.  Early Biomarkers Associated with P53 Signaling for Acute Radiation Injury.

Authors:  Weihong Li; Shixiang Zhou; Meng Jia; Xiaoxin Li; Lin Li; Qi Wang; Zhenhua Qi; Pingkun Zhou; Yaqiong Li; Zhidong Wang
Journal:  Life (Basel)       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.